Log in | Register

Understanding organ dysfunction in Ebola virus disease

Tom E. Fletcher| Robert A. Fowler| Nicholas J. Beeching
Understanding the Disease
Volume 40, Issue 12 / December , 2014

Pages 1936 - 1939

No abstract available.

References

  1. Leroy EM, Gonzalez J-P, Baize S (2011) Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa. Clin Microbiol Infect 17:964–976. doi:10.1111/j.1469-0691.2011.03535.x
    • View reference on publisher's website
  2. Feldmann H, Geisbert TW (2011) Ebola haemorrhagic fever. Lancet 377:849–862. doi:10.1016/S0140-6736(10)60667-8
    • View reference on PubMed
    • View reference on publisher's website
  3. WHO Ebola Response Team (2014) Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections. N Engl J Med. 371:1481–1495. doi:10.1056/NEJMoa1411100
  4. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420:885–891
    • View reference on PubMed
    • View reference on publisher's website
  5. Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840–851. doi:10.1056/NEJMra1208623
    • View reference on PubMed
    • View reference on publisher's website
  6. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med 39(2):165–228. doi:10.1007/s00134-012-2769-8
  7. McElroy AK, Erickson BR, Flietstra TD, Rollin PE, Nichol ST, Towner JS, Spiropolou CF (2014) Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 210(4):558–566. doi:10.1093/infdis/jiu088
    • View reference on PubMed
    • View reference on publisher's website
  8. Bente D, Gren J, Strong JE, Feldmann H (2009) Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2:12–17. doi:10.1242/dmm.000471
    • View reference on PubMed
    • View reference on publisher's website
  9. Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nature Med 10(Suppl 12):S110–121. doi:10.1038/nm1142
    • View reference on PubMed
    • View reference on publisher's website
  10. Mahanty S, Bray M (2004) Pathogenesis of filoviral haemorrhagic fevers. Lancet Infect Dis 4(8):487–498
    • View reference on PubMed
    • View reference on publisher's website
  11. Mohamadzadeh M, Chen L, Schmaljohn AL (2007) How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 7:556–567. doi:10.1038/nri2098
    • View reference on PubMed
    • View reference on publisher's website
  12. Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley LE (2003) Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163:2371–2382
    • View reference on PubMed
    • View reference on publisher's website
  13. Villinger F, Rollin PE, Brar SS, Chikkala NF, Winter J, Sundstrom JB, Zaki SR, Swanepoel R, Ansari AA, Peters CJ (1999) Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis 179(Suppl 1):S188–191. doi:10.1086/514283
    • View reference on PubMed
    • View reference on publisher's website
  14. Hensley LE, Young HA, Jahrling PB, Geisbert TW (2002) Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80:169–179. doi:10.1016/s0165-2478(01)00327-3
  15. Reed DS, Hensley LE, Geisbert JB, Jahrling PB, Geisbert TW (2004) Depletion of peripheral blood T lymphocytes and NK cells during the course of ebolahemorrhagic fever in cynomolgus macaques. Viral Immunol 17:390–400. doi:10.1089/vim.2004.17.390
    • View reference on PubMed
    • View reference on publisher's website
  16. Leblebicioglu H, Bodur H, Dokuzoguz B, Elaldi N, Guner R, Koksal I, Kurt H, Senturk GC (2012) Case management and supportive treatment for patients with Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis 12:805–811. doi:10.1089/vbz.2011.0896
    • View reference on PubMed
    • View reference on publisher's website
  17. Rollin PE, Bausch DG, Sanchez A (2007) Blood chemistry measurements and D-dimer levels associated with fatal and nonfatal outcomes in humans infected with Sudan Ebola Virus. J Infect Dis 196(Suppl 2):S364–371
    • View reference on PubMed
    • View reference on publisher's website
  18. Mupere E, Kaducu OF, Yoti Z (2001) Ebola haemorrhagic fever among hospitalised children and adolescents in nothern Uganda : epidemiologic and clinical observations. Afr Hlth Sci 1(2): 60–65. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2141551/
  19. Goodman JL (2014) Studying “Secret Serums”—toward safe, effective Ebola treatments. N Engl J Med 371:108–1089. doi:10.1056/NEJMp1409817
    • View reference on publisher's website
  20. Fowler RA, Fletcher T, Fischer WA, Lamontagne F, Jacob S, Brett-Major D et al (2014) Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 190(7):733–737
    • View reference on PubMed
    • View reference on publisher's website

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement